Abstract
This protocol describes the synthesis of oligo(poly(ethylene glycol) fumarate) (OPF; 1–35 kDa; a polymer useful for tissue engineering applications) by a one-pot reaction of poly(ethylene glycol) (PEG) and fumaryl chloride. The procedure involves three parts: dichloromethane and PEG are first dried; the reaction step follows, in which fumaryl chloride and triethylamine are added dropwise to a solution of PEG in dichloromethane; and finally, the product solution is filtered to remove by-product salt, and the OPF product is twice crystallized, washed and dried under vacuum. The reaction is affected by the molecular weight of PEG and reactant molar ratio. The OPF product is cross-linked by radical polymerization by either a thermally induced or ultraviolet-induced radical initiator, and the physical properties of the OPF oligomer and resulting cross-linked hydrogel are easily tailored by varying PEG molecular weight. OPF hydrogels are injectable, they polymerize in situ and they undergo biodegradation by hydrolysis of ester bonds. The expected time required to complete this protocol is 6 d.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout





References
Zhu, J. Bioactive modification of poly(ethylene glycol) hydrogels for tissue engineering. Biomaterials 31, 4639–4656 (2010).
Suggs, L.J. & Mikos, A.G. Development of poly(propylene fumarate-co-ethylene glycol) as an injectable carrier for endothelial cells. Cell Transplant 8, 345–350 (1999).
Sarvestani, A.S., Xu, W., He, X. & Jabbari, E. Gelation and degradation characteristics of in situ photo-crosslinked poly(l-lactide-co-ethylene oxide-co-fumarate) hydrogels. Polymer 48, 7113–7120 (2007).
Jo, S., Shin, H., Shung, A.K., Fisher, J.P. & Mikos, A.G. Synthesis and characterization of oligo(poly(ethylene glycol) fumarate) macromer. Macromolecules 34, 2839–2844 (2001).
Temenoff, J.S., Athanasiou, K.A., LeBaron, R.G. & Mikos, A.G. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J. Biomed. Mater. Res. 59, 429–437 (2002).
Shin, H., Temenoff, J.S. & Mikos, A.G. In vitro cytotoxicity of unsaturated oligo[poly(ethylene glycol) fumarate] macromers and their cross-linked hydrogels. Biomacromolecules 4, 552–560 (2003).
Temenoff, J.S., Steinbis, E.S. & Mikos, A.G. Effect of drying history on swelling properties and cell attachment to oligo(poly(ethylene glycol) fumarate) hydrogels for guided tissue regeneration applications. J. Biomater. Sci. Polym. Ed. 14, 989–1004 (2003).
Fisher, J.P. et al. Effect of biomaterial properties on bone healing in a rabbit tooth extraction socket model. J. Biomed. Mater. Res. A 68, 428–438 (2004).
Temenoff, J.S. et al. Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro. Biomacromolecules 5, 5–10 (2004).
Park, H., Temenoff, J.S., Tabata, Y., Caplan, A.I. & Mikos, A.G. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 28, 3217–3227 (2007).
Guo, X. et al. Effects of TGF-β3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. Acta Biomater. 6, 2920–2931 (2010).
Guo, X. et al. Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. Acta Biomater. 6, 39–47 (2010).
Guo, X. et al. In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials 30, 2741–2752 (2009).
Qiu, Y. et al. PEG-based hydrogels with tunable degradation characteristics to control delivery of marrow stromal cells for tendon overuse injuries. Acta Biomater. 7, 959–966 (2011).
Wang, H. et al. Injectable biodegradable hydrogels for embryonic stem cell transplantation: improved cardiac remodeling and function of myocardial infarction. J. Cell. Mol. Med. published online, doi:10.1111/j.1582-4934.2011.01409.x (12 August 2011).
Zhang, M.W. et al. Adapting biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels for pigment epithelial cell encapsulation and lens regeneration. Tissue Eng. Part C Methods 16, 261–267 (2010).
Rooney, G.E. et al. Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels. Tissue Eng. Part A 17, 1287–1302 (2011).
Temenoff, J.S. et al. In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels. J. Biomed. Mater. Res. A 70, 235–244 (2004).
Park, H., Temenoff, J.S., Holland, T.A., Tabata, Y. & Mikos, A.G. Delivery of TGF-β1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 26, 7095–7103 (2005).
Hammoudi, T.M., Lu, H. & Temenoff, J.S. Long-term spatially defined coculture within three-dimensional photopatterned hydrogels. Tissue Eng. Part C Methods 16, 1621–1628 (2010).
Holland, T.A., Tabata, Y. & Mikos, A.G. In vitro release of transforming growth factor-β1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J. Control Release 91, 299–313 (2003).
Holland, T.A., Tessmar, J.K.V., Tabata, Y. & Mikos, A.G. Transforming growth factor-β1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J. Control Release 94, 101–114 (2004).
Holland, T.A., Tabata, Y. & Mikos, A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J. Control Release 101, 111–125 (2005).
Holland, T.A. et al. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage 15, 187–197 (2007).
Holland, T.A. et al. Osteochondral repair in the rabbit model utilizing bilayered, degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds. J. Biomed. Mater. Res. A 75, 156–167 (2005).
Park, H. et al. Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabbit marrow mesenchymal stem cells in vitro. Biomacromolecules 10, 541–546 (2009).
Park, H. et al. Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. J. Biomed. Mater. Res. A 88, 889–897 (2009).
Kasper, F.K., Kushibiki, T., Kimura, Y., Mikos, A.G. & Tabata, Y. In vivo release of plasmid DNA from composites of oligo(poly(ethylene glycol)fumarate) and cationized gelatin microspheres. J. Control Release 107, 547–561 (2005).
Kasper, F.K. et al. In vitro release of plasmid DNA from oligo(poly(ethylene glycol) fumarate) hydrogels. J. Control Release 104, 521–539 (2005).
Kasper, F.K. et al. Characterization of DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in vitro. J. Biomed. Mater. Res. A 78, 823–835 (2006).
Kasper, F.K. et al. Evaluation of bone regeneration by DNA release from composites of oligo(poly(ethylene glycol) fumarate) and cationized gelatin microspheres in a critical-sized calvarial defect. J. Biomed. Mater. Res. A 78, 335–342 (2006).
Henke, M., Brandl, F., Goepferich, A.M. & Tessmar, J.K. Size-dependent release of fluorescent macromolecules and nanoparticles from radically cross-linked hydrogels. Eur. J. Pharm. Biopharm. 74, 184–192 (2010).
Dadsetan, M. et al. A stimuli-responsive hydrogel for doxorubicin delivery. Biomaterials 31, 8051–8062 (2010).
Shin, H., Jo, S. & Mikos, A.G. Modulation of marrow stromal osteoblast adhesion on biomimetic oligo[poly(ethylene glycol) fumarate] hydrogels modified with Arg-Gly-Asp peptides and a poly(ethyleneglycol) spacer. J. Biomed. Mater. Res. 61, 169–179 (2002).
Shin, H., Zygourakis, K., Farach-Carson, M.C., Yaszemski, M.J. & Mikos, A.G. Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials 25, 895–906 (2004).
Shin, H., Zygourakis, K., Farach-Carson, M.C., Yaszemski, M.J. & Mikos, A.G. Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J. Biomed. Mater. Res. A 69, 535–543 (2004).
Jo, S., Shin, H. & Mikos, A.G. Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules 2, 255–261 (2001).
Shin, H. et al. Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate. Biomaterials 26, 3645–3654 (2005).
Bongio, M. et al. Biomimetic modification of synthetic hydrogels by incorporation of adhesive peptides and calcium phosphate nanoparticles: in vitro evaluation of cell behavior. Eur. Cell. Mater. 22, 359–376 (2011).
Leeuwenburgh, S.C.G., Jansen, J.A. & Mikos, A.G. Functionalization of oligo(poly(ethylene glycol)fumarate) hydrogels with finely dispersed calcium phosphate nanocrystals for bone-substituting purposes. J. Biomater. Sci. Polym. Ed. 18, 1547–1564 (2007).
Shin, H., Quinten Ruhé, P., Mikos, A.G. & Jansen, J.A. In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials 24, 3201–3211 (2003).
Temenoff, J.S., Shin, H., Conway, D.E., Engel, P.S. & Mikos, A.G. In vitro cytotoxicity of redox radical initiators for cross-linking of oligo(poly(ethylene glycol) fumarate) macromers. Biomacromolecules 4, 1605–1613 (2003).
Dadsetan, M., Szatkowski, J.P., Yaszemski, M.J. & Lu, L. Characterization of photo-cross-linked oligo[poly(ethylene glycol) fumarate] hydrogels for cartilage tissue engineering. Biomacromolecules 8, 1702–1709 (2007).
Peter, S.J., Suggs, L.J., Yaszemski, M.J., Engel, P.S. & Mikos, A.G. Synthesis of poly(propylene fumarate) by acylation of propylene glycol in the presence of a proton scavenger. J. Biomater. Sci. Polym. Ed. 10, 363–373 (1999).
Wang, S., Lu, L., Gruetzmacher, J.A., Currier, B.L. & Yaszemski, M.J. Synthesis and characterizations of biodegradable and crosslinkable poly(epsilon-caprolactone fumarate), poly(ethylene glycol fumarate), and their amphiphilic copolymer. Biomaterials 27, 832–841 (2006).
Cai, L. & Wang, S. Elucidating colorization in the functionalization of hydroxyl-containing polymers using unsaturated anhydrides/acyl chlorides in the presence of triethylamine. Biomacromolecules 11, 304–307 (2010).
Tanahashi, K. & Mikos, A.G. Cell adhesion on poly(propylene fumarate-co-ethylene glycol) hydrogels. J. Biomed. Mater. Res. 62, 558–566 (2002).
Suggs, L.J. et al. Preparation and characterization of poly(propylene fumarate-co-ethylene glycol) hydrogels. J. Biomater. Sci. Polym. Ed. 9, 653–666 (1998).
Suggs, L.J., Shive, M.S., Garcia, C.A., Anderson, J.M. & Mikos, A.G. In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. J. Biomed. Mater. Res. 46, 22–32 (1999).
Fisher, J.P., Jo, S., Mikos, A.G. & Reddi, A.H. Thermoreversible hydrogel scaffolds for articular cartilage engineering. J. Biomed. Mater. Res. A 71, 268–274 (2004).
He, X. & Jabbari, E. Material properties and cytocompatibility of injectable MMP degradable poly(lactide ethylene oxide fumarate) hydrogel as a carrier for marrow stromal cells. Biomacromolecules 8, 780–792 (2007).
Acknowledgements
The work described in this protocol was supported by grants from the US National Institutes of Health (R01 AR48756) and the Armed Forces Institute of Regenerative Medicine (W81XWH-08-2-0032). L.A.K. acknowledges support from a graduate fellowship from the National Science Foundation (0940902).
Author information
Authors and Affiliations
Contributions
L.A.K., F.K.K. and A.G.M. optimized the procedure. L.A.K. drafted the manuscript. F.K.K. and A.G.M. supervised the project and critically revised the manuscript.
Corresponding author
Ethics declarations
Competing interests
A.G.M. is inventor on a patent involving the material described in this protocol. The remaining authors declare no competing financial interests.
Supplementary information
Supplementary Figure 1
A typical 1H NMR spectrum (400 MHz, CDCl3, ambient temperature) of OPF3K showing chemical shifts of important peaks. (PDF 86 kb)
Rights and permissions
About this article
Cite this article
Kinard, L., Kasper, F. & Mikos, A. Synthesis of oligo(poly(ethylene glycol) fumarate). Nat Protoc 7, 1219–1227 (2012). https://doi.org/10.1038/nprot.2012.055
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2012.055
This article is cited by
-
In situ forming hydrogels based on polyethylene glycol itaconate for tissue engineering application
Bulletin of Materials Science (2019)
-
A composite critical-size rabbit mandibular defect for evaluation of craniofacial tissue regeneration
Nature Protocols (2016)
-
Evaluation of Gelatin Microparticles as Adherent-Substrates for Mesenchymal Stem Cells in a Hydrogel Composite
Annals of Biomedical Engineering (2016)
-
Bone Morphogenetic Protein-2 Release from Composite Hydrogels of Oligo(poly(ethylene glycol) fumarate) and Gelatin
Pharmaceutical Research (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.